About this reference

Clear information.
Traceable evidence.

This website brings together product information and published research on Pegpesen (inpegsomatropin) for professional reference.

How to use the material

Begin with the product reference for local label summaries, or the research library for clinical studies and emerging findings. Review the original source before applying a summary to clinical practice.

Evidence is identified by type

Randomized trials, modeling studies, evidence syntheses, and conference abstracts answer different questions. Conference findings and simulated dosing strategies are labeled explicitly.

Product and source attribution

Pegpesen is developed by Xiamen Amoytop Biotech. Product images are attributed to the manufacturer; journal and conference summaries link to the original publications. Product names and trademarks belong to their respective owners.

Scope

Authorization, indications, and dosing can differ between countries. These English-language summaries do not replace the locally approved prescribing information or individualized clinical judgment.